Combination Therapy in Moderate to Severe Alzheimer’s Disease - Overview and Discussion Points for the Future

European Neurological Review - United Kingdom
doi 10.17925/enr.2011.06.04.228
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Initial Combination Therapy With Olmesartan/Hydrochlorothiazide in Moderate-To-Severe Hypertension

Journal of Human Hypertension
Internal Medicine
2006English

Modelling the Cost-Effectiveness of Pharmacotherapy Compared With Cognitive–behavioural Therapy and Combination Therapy for the Treatment of Moderate to Severe Depression in the UK

Psychological Medicine
PsychiatryMental HealthApplied Psychology
2015English

Technology-Aided Programs to Support Positive Verbal and Physical Engagement in Persons With Moderate or Severe Alzheimer’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2016English

Safety and Tolerability of Low-Dose Naltrexone Therapy in Children With Moderate to Severe Crohn’s Disease

Journal of Clinical Gastroenterology
Gastroenterology
2013English

Effect of TTP488 in Patients With Mild to Moderate Alzheimer’s Disease

BMC Neurology
MedicineNeurology
2014English

Cost-Effectiveness Analysis of Memantine for Moderate-To-Severe Alzheimer's Disease in the Netherlands

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2011English

Eosinophils Target Therapy for Severe Asthma: Critical Points

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Pathophysiology and Management of Alzheimer’s Disease: An Overview

Journal of Analytical & Pharmaceutical Research
2018English

Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression

Archives of General Psychiatry
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy